Murine sca1/flk1-positive cells are not endothelial progenitor cells, but B2 lymphocytes

[1]  D. Tsiantoulas,et al.  The role of B cells in atherosclerosis , 2018, Nature Reviews Cardiology.

[2]  M. Yoder.  Endothelial stem and progenitor cells (stem cells): (2017 Grover Conference Series) , 2017, Pulmonary circulation.

[3]  E. Curti,et al.  Deciphering pore-level precipitation mechanisms , 2017, Scientific Reports.

[4]  A. Tedgui,et al.  Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells , 2017, Scientific Reports.

[5]  W. Han,et al.  Granulocyte-Colony Stimulating Factor (G-CSF) Accelerates Wound Healing in Hemorrhagic Shock Rats by Enhancing Angiogenesis and Attenuating Apoptosis , 2017, Medical science monitor : international medical journal of experimental and clinical research.

[6]  J. L. de la Pompa,et al.  Marginal zone B cells control the response of follicular helper T cells to a high-cholesterol diet , 2017, Nature Medicine.

[7]  Alan W. Stitt,et al.  Endothelial Progenitors: A Consensus Statement on Nomenclature , 2017, Stem cells translational medicine.

[8]  S. Zimmer,et al.  Mobilization of sca1/flk-1 positive endothelial progenitor cells declines in apolipoprotein E-deficient mice with a high-fat diet. , 2015, Journal of cardiology.

[9]  M. Menon,et al.  The expanding family of regulatory B cells , 2015, International immunology.

[10]  M. Goddard,et al.  B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10 , 2015, Thrombosis and Haemostasis.

[11]  E. Rosser,et al.  Regulatory B cells: origin, phenotype, and function. , 2015, Immunity.

[12]  R. de Caterina,et al.  Circulating endothelial progenitor cells: Do they live up to their name? , 2015, Vascular pharmacology.

[13]  Z. Mallat,et al.  Multiple potential roles for B cells in atherosclerosis , 2014, Annals of medicine.

[14]  D. Noonan,et al.  Orchestration of Angiogenesis by Immune Cells , 2014, Front. Oncol..

[15]  T. Hellevik,et al.  Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation , 2014, Front. Oncol..

[16]  Hua Yu,et al.  B Cells Promote Tumor Progression via STAT3 Regulated-Angiogenesis , 2013, PloS one.

[17]  Alan Bensoussan,et al.  Traditional Chinese Medicine in Cancer Care: A Review of Controlled Clinical Studies Published in Chinese , 2013, PloS one.

[18]  G. Nickenig,et al.  Atorvastatin-induced increase in progenitor cell levels is rather caused by enhanced receptor activator of NF-kappaB ligand (RANKL) cell proliferation than by bone marrow mobilization. , 2013, Journal of molecular and cellular cardiology.

[19]  S. Dimmeler,et al.  Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use , 2012, Circulation research.

[20]  Hong Wang,et al.  Endothelial progenitor cells in atherosclerosis. , 2012, Frontiers in bioscience.

[21]  L. Santos‐Argumedo,et al.  CD38 through the life of a murine B lymphocyte , 2011, IUBMB life.

[22]  Aruni Bhatnagar,et al.  Acrolein Inhalation Prevents Vascular Endothelial Growth Factor–Induced Mobilization of Flk-1+/Sca-1+ Cells in Mice , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[23]  C. Coch,et al.  Activation of Endothelial Toll-Like Receptor 3 Impairs Endothelial Function , 2011, Circulation research.

[24]  P. Libby,et al.  Progress and challenges in translating the biology of atherosclerosis , 2011, Nature.

[25]  M. Yoder,et al.  Endothelial progenitor cells: quo vadis? , 2011, Journal of molecular and cellular cardiology.

[26]  P. Tipping,et al.  Conventional B2 B Cell Depletion Ameliorates whereas Its Adoptive Transfer Aggravates Atherosclerosis , 2010, The Journal of Immunology.

[27]  Takashi Ito,et al.  B Cell-Derived Vascular Endothelial Growth Factor A Promotes Lymphangiogenesis and High Endothelial Venule Expansion in Lymph Nodes , 2010, The Journal of Immunology.

[28]  G. Nickenig,et al.  Endothelial-Regenerating Cells: An Expanding Universe , 2010, Hypertension.

[29]  E. Falk,et al.  Circulating Endothelial Progenitor Cells Do Not Contribute to Plaque Endothelium in Murine Atherosclerosis , 2010, Circulation.

[30]  D. Isenberg,et al.  CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. , 2010, Immunity.

[31]  G. Nickenig,et al.  Synergistic effects of telmisartan and simvastatin on endothelial progenitor cells , 2009, Journal of cellular and molecular medicine.

[32]  F. Timmermans,et al.  Endothelial progenitor cells: identity defined? , 2008, Journal of cellular and molecular medicine.

[33]  M. Yoder,et al.  Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. , 2007, Experimental hematology.

[34]  G. Nickenig,et al.  Endothelial progenitor cells in health and atherosclerotic disease , 2007, Annals of medicine.

[35]  G. Nickenig,et al.  Improvement of Endothelial Function by Systemic Transfusion of Vascular Progenitor Cells , 2006, Circulation research.

[36]  Qingbo Xu,et al.  Sca-1+ Progenitors Derived From Embryonic Stem Cells Differentiate Into Endothelial Cells Capable of Vascular Repair After Arterial Injury , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[37]  Y. Shiba,et al.  Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice. , 2006, Cardiovascular research.

[38]  G. Nickenig,et al.  CD34−/CD133+/VEGFR-2+ Endothelial Progenitor Cell Subpopulation With Potent Vasoregenerative Capacities , 2006, Circulation research.

[39]  G. Nickenig,et al.  Circulating endothelial progenitor cells and cardiovascular outcomes. , 2005, The New England journal of medicine.

[40]  S. Fichtlscherer,et al.  Reduced Number of Circulating Endothelial Progenitor Cells Predicts Future Cardiovascular Events: Proof of Concept for the Clinical Importance of Endogenous Vascular Repair , 2005, Circulation.

[41]  J. P. McCoy,et al.  Granulocyte Colony-Stimulating Factor Mobilizes Functional Endothelial Progenitor Cells in Patients With Coronary Artery Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[42]  P. Ganz,et al.  Role of Endothelial Dysfunction in Atherosclerosis , 2004, Circulation.

[43]  H. Drexler,et al.  Endothelial function: a critical determinant in atherosclerosis? , 2004, Circulation.

[44]  W. Schaper,et al.  Bone marrow-Derived Cells Do Not Incorporate Into the Adult Growing Vasculature , 2004, Circulation research.

[45]  U. Laufs,et al.  Intravenous Transfusion of Endothelial Progenitor Cells Reduces Neointima Formation After Vascular Injury , 2003, Circulation research.

[46]  R. Taichman,et al.  G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4 , 2002, Nature Immunology.

[47]  S. Fichtlscherer,et al.  Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.

[48]  J. Bluestone,et al.  Effect of Immune Deficiency on Lipoproteins and Atherosclerosis in Male Apolipoprotein E-Deficient Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[49]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.